MIDAZOLAM

MIDAZOLAM was reported 27286 times

MIDAZOLAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 130 0.4290
1 MITOCHONDRIAL DNA MUTATION 36 0.4186
2 TRIGEMINO-CARDIAC REFLEX 27 0.3333
3 NEW ONSET REFRACTORY STATUS EPILEPTICUS 35 0.3182
4 CHEST WALL RIGIDITY 18 0.2812
5 NEGATIVE PRESSURE PULMONARY OEDEMA 26 0.2653
6 PROPOFOL INFUSION SYNDROME 154 0.2184
7 CSF OLIGOCLONAL BAND PRESENT 24 0.1846
8 INTRA-ABDOMINAL PRESSURE INCREASED 26 0.1656
9 BURKHOLDERIA TEST POSITIVE 20 0.1613
10 ANAL PROLAPSE 19 0.1610
11 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 56 0.1474
12 AIRWAY PEAK PRESSURE INCREASED 20 0.1316
13 MYOGLOBIN URINE PRESENT 29 0.1179
14 UNWANTED AWARENESS DURING ANAESTHESIA 37 0.1128
15 ANAESTHETIC COMPLICATION NEUROLOGICAL 98 0.1082
16 MYOCARDIAL DEPRESSION 27 0.1047
17 NECROSIS ISCHAEMIC 45 0.0976
18 NEUROMUSCULAR BLOCK PROLONGED 36 0.0976
19 POSTOPERATIVE DELIRIUM 19 0.0960
20 MULTIPLE-DRUG RESISTANCE 294 0.0947
21 HEPATIC ISCHAEMIA 29 0.0932
22 HYPERTHERMIA MALIGNANT 134 0.0900
23 NEUROMUSCULAR BLOCKADE 20 0.0893
24 VAGAL NERVE STIMULATOR IMPLANTATION 27 0.0882
25 SEIZURE CLUSTER 71 0.0856
26 FEMALE GENITAL TRACT FISTULA 141 0.0825
27 AIRWAY COMPLICATION OF ANAESTHESIA 21 0.0798
28 CARCINOID CRISIS 17 0.0752
29 DELAYED RECOVERY FROM ANAESTHESIA 66 0.0696
30 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 68 0.0640
31 STATUS EPILEPTICUS 670 0.0593
32 NEONATAL RESPIRATORY DEPRESSION 19 0.0572
33 PNEUMATOSIS 24 0.0538
34 PROCTITIS 150 0.0535
35 UPPER AIRWAY OBSTRUCTION 47 0.0530
36 RADICULOPATHY 137 0.0519
37 TACHYPHYLAXIS 18 0.0516
38 ACIDOSIS HYPERCHLORAEMIC 30 0.0505
39 BLOOD GASES ABNORMAL 27 0.0501
40 DIABETES INSIPIDUS 120 0.0498
41 VOCAL CORD DYSFUNCTION 23 0.0467
42 PLEOCYTOSIS 27 0.0464
43 PROCEDURAL HYPOTENSION 37 0.0435
44 SEDATION COMPLICATION 108 0.0423
45 RESPIRATORY ACIDOSIS 152 0.0386
46 CHRONIC SINUSITIS 141 0.0375
47 CHANGE IN SEIZURE PRESENTATION 24 0.0371
48 LABILE BLOOD PRESSURE 44 0.0370
49 BULIMIA NERVOSA 16 0.0364
50 ADENOMA BENIGN 31 0.0360
51 PO2 INCREASED 18 0.0355
52 MYOCLONIC EPILEPSY 53 0.0349
53 ABDOMINAL COMPARTMENT SYNDROME 21 0.0330
54 RENAL ISCHAEMIA 18 0.0329
55 CLONIC CONVULSION 24 0.0328
56 MACROGLOSSIA 18 0.0327
57 PARADOXICAL DRUG REACTION 119 0.0323
58 PROCEDURAL VOMITING 21 0.0323
59 DERMATOSIS 20 0.0320
60 ENCEPHALITIS AUTOIMMUNE 42 0.0319
61 PARTIAL SEIZURES 166 0.0317
62 ENDOTRACHEAL INTUBATION COMPLICATION 18 0.0305
63 TONIC CONVULSION 43 0.0303
64 TONIC CLONIC MOVEMENTS 39 0.0300
65 KOUNIS SYNDROME 68 0.0299
66 PCO2 INCREASED 21 0.0295
67 PULSELESS ELECTRICAL ACTIVITY 122 0.0292
68 ELECTROENCEPHALOGRAM ABNORMAL 92 0.0291
69 LARYNGEAL STENOSIS 16 0.0277
70 ANTICHOLINERGIC SYNDROME 44 0.0276
71 HYPERCAPNIA 81 0.0269
72 MATERNAL EXPOSURE DURING DELIVERY 26 0.0262
73 SYMPTOM MASKED 19 0.0261
74 DELAYED GRAFT FUNCTION 18 0.0253
75 HYPOVENTILATION 81 0.0248
76 SEROTONIN SYNDROME 464 0.0241
77 BRADYCARDIA FOETAL 20 0.0241
78 ANAESTHETIC COMPLICATION 64 0.0238
79 HAEMODYNAMIC INSTABILITY 179 0.0235
80 APALLIC SYNDROME 17 0.0234
81 ATONIC SEIZURES 20 0.0233
82 VASOPLEGIA SYNDROME 38 0.0232
83 CERUMEN IMPACTION 21 0.0229
84 GENERALISED TONIC-CLONIC SEIZURE 376 0.0227
85 HYPERAMMONAEMIC ENCEPHALOPATHY 39 0.0224
86 SUBCUTANEOUS EMPHYSEMA 22 0.0224
87 RESPIRATORY DEPRESSION 274 0.0223
88 AUTONOMIC NERVOUS SYSTEM IMBALANCE 65 0.0222
89 FOCAL DYSCOGNITIVE SEIZURES 25 0.0219
90 FIBROMA 20 0.0218
91 BRAIN HYPOXIA 21 0.0209
92 MYOCLONUS 243 0.0204
93 CARDIOVASCULAR INSUFFICIENCY 33 0.0203
94 PUPILS UNEQUAL 23 0.0201
95 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 66 0.0199
96 BRAIN DEATH 59 0.0191
97 NEPHROGENIC DIABETES INSIPIDUS 22 0.0191
98 ENDOTRACHEAL INTUBATION 53 0.0189
99 INTESTINAL ISCHAEMIA 104 0.0189
100 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 20 0.0188
101 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 71 0.0186
102 LONG QT SYNDROME 44 0.0183
103 CLONUS 50 0.0183
104 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 40 0.0182
105 METHAEMOGLOBINAEMIA 42 0.0181
106 SINUS ARREST 28 0.0178
107 SEIZURE LIKE PHENOMENA 30 0.0177
108 APNOEA 137 0.0176
109 BLOOD LACTIC ACID INCREASED 92 0.0174
110 HYPORESPONSIVE TO STIMULI 20 0.0170
111 HYPERTHERMIA 129 0.0169
112 MUCOSAL ULCERATION 17 0.0168
113 TOXIC ENCEPHALOPATHY 85 0.0168
114 GENE MUTATION 33 0.0167
115 HEPATORENAL SYNDROME 28 0.0166
116 FANCONI SYNDROME 23 0.0163
117 OEDEMA MUCOSAL 17 0.0162
118 STRESS CARDIOMYOPATHY 94 0.0161
119 HYPERAMMONAEMIA 80 0.0160
120 BEZOAR 22 0.0159
121 LARYNGOSPASM 42 0.0156
122 VULVOVAGINAL CANDIDIASIS 21 0.0155
123 HYPERTROPHIC CARDIOMYOPATHY 24 0.0155
124 ISCHAEMIC HEPATITIS 21 0.0153
125 COMPLEX PARTIAL SEIZURES 17 0.0153
126 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 40 0.0153
127 ACIDOSIS 116 0.0152
128 NECROTISING COLITIS 19 0.0150
129 BRAIN OEDEMA 189 0.0149
130 HYPERNATRAEMIA 74 0.0148
131 BLOOD PH DECREASED 25 0.0146
132 OXYGEN THERAPY 24 0.0146
133 DRUG CLEARANCE DECREASED 19 0.0145
134 PUPIL FIXED 25 0.0144
135 CATATONIA 75 0.0143
136 WHITE MATTER LESION 18 0.0142
137 MULTIPLE ORGAN DYSFUNCTION SYNDROME 402 0.0142
138 SEIZURE 1639 0.0142
139 BRADYPNOEA 38 0.0141
140 QUADRIPARESIS 23 0.0138
141 PNEUMOMEDIASTINUM 25 0.0138
142 OXYGEN SATURATION ABNORMAL 39 0.0137
143 ACUTE LUNG INJURY 16 0.0135
144 NEPHROGENIC ANAEMIA 62 0.0134
145 HYPOXIA 470 0.0133
146 STRIDOR 39 0.0132
147 MYOGLOBIN BLOOD INCREASED 20 0.0131
148 BRAIN HERNIATION 39 0.0130
149 MIXED LIVER INJURY 39 0.0129
150 METABOLIC ACIDOSIS 407 0.0127
151 VAGINAL DISCHARGE 128 0.0126
152 ORAL CANDIDIASIS 165 0.0125
153 LEFT VENTRICULAR HYPERTROPHY 53 0.0124
154 VENTRICULAR ARRHYTHMIA 45 0.0123
155 HYPERKINESIA 26 0.0123
156 RENAL NEOPLASM 26 0.0122
157 ACUTE RESPIRATORY DISTRESS SYNDROME 215 0.0121
158 QUADRIPLEGIA 25 0.0121
159 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32 0.0120
160 SUPERINFECTION 18 0.0120
161 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 61 0.0119
162 KLEBSIELLA INFECTION 60 0.0119
163 NEUROLEPTIC MALIGNANT SYNDROME 140 0.0118
164 ANTICONVULSANT DRUG LEVEL INCREASED 19 0.0118
165 INTRA-ABDOMINAL HAEMORRHAGE 28 0.0117
166 BEHAVIOUR DISORDER 63 0.0116
167 VENTRICULAR HYPOKINESIA 37 0.0115
168 EXTREMITY NECROSIS 20 0.0115
169 CIRCULATORY COLLAPSE 195 0.0114
170 AXILLARY PAIN 17 0.0114
171 PETIT MAL EPILEPSY 58 0.0113
172 AREFLEXIA 30 0.0112
173 STUPOR 36 0.0112
174 CELL DEATH 22 0.0111
175 UNRESPONSIVE TO STIMULI 285 0.0110
176 MUSCLE RIGIDITY 131 0.0109
177 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104 0.0109
178 ILLUSION 18 0.0109
179 PSEUDOMONAL SEPSIS 19 0.0108
180 TROPONIN I INCREASED 18 0.0108
181 MACULAR DEGENERATION 127 0.0106
182 ANAPHYLACTIC REACTION 584 0.0106
183 AMYLASE INCREASED 39 0.0106
184 BLOOD BICARBONATE DECREASED 20 0.0106
185 VENTRICULAR FIBRILLATION 117 0.0105
186 RESPIRATORY RATE DECREASED 33 0.0105
187 RESPIRATORY ALKALOSIS 17 0.0104
188 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 269 0.0104
189 ANAPHYLACTIC SHOCK 269 0.0104
190 RHABDOMYOLYSIS 432 0.0103
191 CARDIAC ARREST 853 0.0103
192 ABDOMINAL RIGIDITY 28 0.0103
193 DELIRIUM 358 0.0103
194 CARDIOGENIC SHOCK 148 0.0103
195 ELECTROCARDIOGRAM T WAVE ABNORMAL 16 0.0102
196 HYPOTONIA NEONATAL 16 0.0102
197 BRONCHOSPASM 146 0.0102
198 NYSTAGMUS 54 0.0102
199 DISTRIBUTIVE SHOCK 23 0.0101
200 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 556 0.0101
201 CATHETER SITE HAEMORRHAGE 25 0.0100
202 BRADYCARDIA 530 0.0100
203 PULSE ABSENT 47 0.0099
204 TACHYPNOEA 134 0.0098
205 SINUS BRADYCARDIA 95 0.0098
206 DYSCHEZIA 30 0.0098
207 HEPATITIS FULMINANT 29 0.0098
208 DISSEMINATED INTRAVASCULAR COAGULATION 137 0.0097
209 LANGUAGE DISORDER 21 0.0097
210 PNEUMONIA STAPHYLOCOCCAL 19 0.0096
211 PATENT DUCTUS ARTERIOSUS 38 0.0096
212 ENTEROBACTER INFECTION 16 0.0095
213 NEUROLOGICAL DECOMPENSATION 22 0.0095
214 MECHANICAL VENTILATION 18 0.0095
215 HYPERREFLEXIA 33 0.0095
216 DEVICE RELATED SEPSIS 19 0.0094
217 MYDRIASIS 121 0.0094
218 GAZE PALSY 16 0.0094
219 INCREASED BRONCHIAL SECRETION 24 0.0094
220 OLIGURIA 58 0.0093
221 SHOCK 212 0.0092
222 HYPOTONIA 92 0.0092
223 PUPILLARY REFLEX IMPAIRED 17 0.0092
224 STARING 22 0.0091
225 ANURIA 78 0.0091
226 TOXIC EPIDERMAL NECROLYSIS 137 0.0090
227 HYPERTRANSAMINASAEMIA 62 0.0089
228 ENCEPHALOPATHY 218 0.0089
229 PNEUMONIA FUNGAL 35 0.0089
230 VENTRICULAR TACHYCARDIA 146 0.0088
231 TORSADE DE POINTES 69 0.0088
232 HYPERPARATHYROIDISM SECONDARY 22 0.0088
233 RESPIRATORY FAILURE 638 0.0087
234 PARAESTHESIA ORAL 126 0.0087
235 DRUG LEVEL BELOW THERAPEUTIC 48 0.0087
236 CEREBRAL ATROPHY 34 0.0085
237 ARTERIOSPASM CORONARY 34 0.0085
238 INTRACRANIAL PRESSURE INCREASED 47 0.0084
239 HYPERPHOSPHATAEMIA 18 0.0084
240 HYPOVOLAEMIA 48 0.0082
241 SHOCK HAEMORRHAGIC 66 0.0081
242 ACUTE RESPIRATORY FAILURE 155 0.0080
243 ANAPHYLACTOID REACTION 33 0.0080
244 PUSTULE 19 0.0080
245 IRON DEFICIENCY 36 0.0080
246 ALTERED STATE OF CONSCIOUSNESS 172 0.0079
247 COMA SCALE ABNORMAL 23 0.0079
248 RASH MORBILLIFORM 22 0.0079
249 HEPATOCELLULAR INJURY 112 0.0079
250 VENTRICULAR EXTRASYSTOLES 82 0.0079
251 FAECAL CALPROTECTIN INCREASED 25 0.0079
252 PULMONARY ALVEOLAR HAEMORRHAGE 44 0.0078
253 DEPRESSED LEVEL OF CONSCIOUSNESS 309 0.0078
254 EPILEPSY 238 0.0078
255 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
256 TROPONIN INCREASED 59 0.0077
257 SINUS TACHYCARDIA 110 0.0077
258 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
259 COAGULOPATHY 128 0.0077
260 AGITATION 554 0.0075
261 SUPRAVENTRICULAR TACHYCARDIA 72 0.0075
262 OXYGEN SATURATION DECREASED 419 0.0074
263 COMA 355 0.0074
264 THROMBOPHLEBITIS 26 0.0074
265 VENTRICULAR DYSFUNCTION 19 0.0073
266 PARAPLEGIA 21 0.0073
267 DRUG INTERACTION 1152 0.0073
268 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
269 MIOSIS 58 0.0072
270 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 54 0.0072
271 CARDIOPULMONARY FAILURE 28 0.0072
272 MULTI-ORGAN FAILURE 124 0.0072
273 LEFT VENTRICULAR DYSFUNCTION 48 0.0072
274 RESPIRATORY ARREST 197 0.0071
275 HYPERLACTACIDAEMIA 19 0.0071
276 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 43 0.0071
277 FREQUENT BOWEL MOVEMENTS 190 0.0070
278 ACUTE HEPATIC FAILURE 96 0.0070
279 COLITIS 265 0.0070
280 HYPOTENSION 1399 0.0070
281 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 23 0.0070
282 TACHYCARDIA 618 0.0069
283 ACUTE PULMONARY OEDEMA 39 0.0069
284 SUBDURAL HAEMORRHAGE 19 0.0069
285 HYPERAESTHESIA 57 0.0069
286 CHOLESTASIS 133 0.0069
287 SEPTIC SHOCK 299 0.0069
288 POTENTIATING DRUG INTERACTION 23 0.0068
289 POLYURIA 56 0.0068
290 SEDATION 179 0.0068
291 ATELECTASIS 66 0.0068
292 DRUG DIVERSION 42 0.0068
293 BUNDLE BRANCH BLOCK RIGHT 31 0.0067
294 ILEUS PARALYTIC 30 0.0067
295 ELECTROCARDIOGRAM QT PROLONGED 241 0.0067
296 APPENDICITIS PERFORATED 17 0.0067
297 HYPERTRIGLYCERIDAEMIA 39 0.0067
298 ENCEPHALITIS 46 0.0066
299 HYPERTONIA 38 0.0066
300 HYPERBILIRUBINAEMIA 68 0.0066
301 DRUG LEVEL ABOVE THERAPEUTIC 30 0.0065
302 ISCHAEMIA 30 0.0065
303 PNEUMONIA ASPIRATION 163 0.0065
304 NECROTISING FASCIITIS 23 0.0065
305 WRONG PRODUCT ADMINISTERED 44 0.0065
306 CYANOSIS 102 0.0065
307 LEUKOCYTOSIS 117 0.0065
308 FUNCTIONAL GASTROINTESTINAL DISORDER 22 0.0064
309 HEPATIC CYTOLYSIS 81 0.0063
310 ATRIOVENTRICULAR BLOCK 49 0.0063
311 PSEUDOMONAS INFECTION 54 0.0063
312 THROMBOCYTOSIS 23 0.0063
313 ANGLE CLOSURE GLAUCOMA 16 0.0063
314 HYPOTHERMIA 63 0.0062
315 PNEUMOTHORAX 98 0.0062
316 RESPIRATORY DISTRESS 170 0.0062
317 BLOOD CREATINE PHOSPHOKINASE INCREASED 177 0.0061
318 COMPARTMENT SYNDROME 16 0.0061
319 PROCEDURAL COMPLICATION 47 0.0061
320 COVID-19 PNEUMONIA 72 0.0061
321 CARDIO-RESPIRATORY ARREST 254 0.0061
322 PREMATURE DELIVERY 96 0.0060
323 ASPIRATION 66 0.0060
324 BRAIN INJURY 60 0.0060
325 MYOCARDIAL ISCHAEMIA 68 0.0060
326 LOW BIRTH WEIGHT BABY 47 0.0059
327 RHINOVIRUS INFECTION 23 0.0059
328 ILEUS 73 0.0059
329 ACUTE KIDNEY INJURY 895 0.0058
330 BACTERAEMIA 69 0.0058
331 TRISMUS 30 0.0058
332 DRUG LEVEL INCREASED 96 0.0058
333 THROMBOTIC MICROANGIOPATHY 56 0.0057
334 ELECTROCARDIOGRAM ABNORMAL 45 0.0057
335 HEPATITIS ACUTE 37 0.0057
336 TYPE I HYPERSENSITIVITY 20 0.0057
337 TRICUSPID VALVE INCOMPETENCE 45 0.0057
338 PULMONARY HAEMORRHAGE 43 0.0055
339 CARDIOTOXICITY 49 0.0055
340 HYPOPNOEA 19 0.0055
341 DRUG RESISTANCE 140 0.0054
342 HEPATIC FAILURE 164 0.0054
343 ACUTE CORONARY SYNDROME 45 0.0054
344 AORTIC VALVE INCOMPETENCE 23 0.0054
345 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 32 0.0054
346 ATAXIA 64 0.0054
347 DERMATITIS BULLOUS 39 0.0054
348 PREMATURE BABY 162 0.0054
349 LACTIC ACIDOSIS 174 0.0054
350 MALABSORPTION 28 0.0054
351 DYSTONIA 104 0.0054
352 FOETAL GROWTH RESTRICTION 32 0.0053
353 ANAL INCONTINENCE 47 0.0052
354 TOXICITY TO VARIOUS AGENTS 881 0.0052
355 FOETAL DEATH 27 0.0052
356 BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0052
357 FEBRILE BONE MARROW APLASIA 22 0.0052
358 ESCHERICHIA URINARY TRACT INFECTION 22 0.0052
359 URINE OUTPUT DECREASED 45 0.0051
360 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26 0.0051
361 PSYCHOMOTOR HYPERACTIVITY 85 0.0051
362 LUNG INFILTRATION 45 0.0051
363 PRODUCT CONTAMINATION 18 0.0051
364 HYPOALBUMINAEMIA 39 0.0050
365 RIGHT VENTRICULAR FAILURE 35 0.0050
366 ELECTROLYTE IMBALANCE 58 0.0050
367 CARBOHYDRATE ANTIGEN 125 INCREASED 17 0.0050
368 APLASTIC ANAEMIA 26 0.0050
369 ERYSIPELAS 25 0.0050
370 NEUROTOXICITY 87 0.0050
371 ORGAN FAILURE 20 0.0050
372 HYPOKALAEMIA 229 0.0050
373 HYPERPYREXIA 21 0.0050
374 RASH MACULO-PAPULAR 110 0.0049
375 DRUG TOLERANCE 25 0.0049
376 POISONING 62 0.0049
377 HYPERKALAEMIA 173 0.0049
378 EOSINOPHILIA 86 0.0049
379 AMMONIA INCREASED 25 0.0049
380 COLITIS ISCHAEMIC 33 0.0049
381 LARYNGEAL OEDEMA 30 0.0049
382 FEAR 130 0.0048
383 HEPATITIS CHOLESTATIC 29 0.0048
384 MITRAL VALVE INCOMPETENCE 54 0.0048
385 BUNDLE BRANCH BLOCK LEFT 20 0.0047
386 MONOCYTE COUNT INCREASED 17 0.0047
387 ATRIOVENTRICULAR BLOCK COMPLETE 31 0.0046
388 HYPOVOLAEMIC SHOCK 22 0.0046
389 COLITIS ULCERATIVE 205 0.0046
390 PRODUCT PREPARATION ISSUE 30 0.0046
391 CARDIAC DYSFUNCTION 17 0.0046
392 MELANOCYTIC NAEVUS 20 0.0046
393 CARDIOMEGALY 56 0.0045
394 RECTAL HAEMORRHAGE 195 0.0045
395 POISONING DELIBERATE 43 0.0045
396 HYPOMAGNESAEMIA 63 0.0045
397 DRUG USE DISORDER 38 0.0045
398 RESPIRATORY RATE INCREASED 40 0.0045
399 THERAPY NON-RESPONDER 201 0.0045
400 PULMONARY OEDEMA 197 0.0044
401 TOXIC SKIN ERUPTION 44 0.0044
402 BLOOD MAGNESIUM DECREASED 37 0.0043
403 CEREBRAL ISCHAEMIA 22 0.0043
404 ANAL ABSCESS 23 0.0043
405 HEPARIN-INDUCED THROMBOCYTOPENIA 21 0.0043
406 PROCEDURAL PAIN 118 0.0042
407 PULMONARY CONGESTION 56 0.0042
408 PERIORBITAL OEDEMA 22 0.0042
409 OBSTRUCTIVE AIRWAYS DISORDER 47 0.0042
410 ABSCESS LIMB 18 0.0042
411 RENAL INJURY 125 0.0042
412 NEUTROPENIC SEPSIS 30 0.0042
413 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 30 0.0042
414 LARGE INTESTINE POLYP 29 0.0042
415 MENTAL STATUS CHANGES 116 0.0042
416 CORONARY ARTERY STENOSIS 21 0.0042
417 CYTOKINE RELEASE SYNDROME 83 0.0041
418 REFUSAL OF TREATMENT BY PATIENT 27 0.0041
419 TRANSAMINASES INCREASED 91 0.0041
420 VARICOSE VEIN 21 0.0041
421 BREATH SOUNDS ABNORMAL 20 0.0041
422 RENAL CYST 32 0.0040
423 INTESTINAL PERFORATION 45 0.0040
424 FACIAL PARALYSIS 34 0.0040
425 BLOOD PRESSURE SYSTOLIC DECREASED 18 0.0040
426 EYE MOVEMENT DISORDER 27 0.0039
427 PATHOLOGICAL FRACTURE 20 0.0039
428 PULMONARY HYPERTENSION 82 0.0039
429 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 279 0.0039
430 RESPIRATION ABNORMAL 27 0.0039
431 THROMBOCYTOPENIA 438 0.0039
432 AGGRESSION 196 0.0039
433 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
434 DYSKINESIA 159 0.0039
435 PARALYSIS 56 0.0039
436 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
437 HYPOCALCAEMIA 74 0.0039
438 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
439 RENAL CELL CARCINOMA 19 0.0039
440 RENAL TUBULAR NECROSIS 38 0.0039
441 ARRHYTHMIA 182 0.0038
442 DRUG LEVEL DECREASED 39 0.0038
443 DRUG-INDUCED LIVER INJURY 120 0.0038
444 COGNITIVE DISORDER 178 0.0038
445 HAEMATEMESIS 96 0.0038
446 POST PROCEDURAL HAEMORRHAGE 44 0.0038
447 NECROSIS 21 0.0038
448 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
449 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
450 GRAFT VERSUS HOST DISEASE 27 0.0038
451 URINARY RETENTION 125 0.0037
452 APHTHOUS ULCER 29 0.0037
453 ANAL FISSURE 20 0.0037
454 EXTRASYSTOLES 26 0.0037
455 NEUTROPHIL COUNT INCREASED 38 0.0037
456 PNEUMONIA BACTERIAL 34 0.0037
457 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16 0.0037
458 MOUTH HAEMORRHAGE 27 0.0037
459 GRAND MAL CONVULSION 34 0.0037
460 HYDROCEPHALUS 20 0.0037
461 HYPERVOLAEMIA 18 0.0036
462 ABSCESS 58 0.0036
463 INFLAMMATORY MARKER INCREASED 18 0.0036
464 ALANINE AMINOTRANSFERASE INCREASED 222 0.0036
465 BLOOD PROLACTIN INCREASED 17 0.0036
466 CARDIAC FAILURE ACUTE 24 0.0036
467 BLOOD UREA INCREASED 60 0.0036
468 RESTLESSNESS 131 0.0036
469 PROCTALGIA 23 0.0036
470 ANHEDONIA 94 0.0036
471 HAEMOLYTIC ANAEMIA 32 0.0036
472 REBOUND EFFECT 40 0.0035
473 EJECTION FRACTION DECREASED 55 0.0035
474 CHOLECYSTITIS ACUTE 20 0.0035
475 RENAL IMPAIRMENT 296 0.0035
476 NORMAL NEWBORN 19 0.0035
477 RENAL FAILURE 463 0.0035
478 APHASIA 105 0.0035
479 BLOOD CALCIUM DECREASED 39 0.0035
480 BLOOD POTASSIUM INCREASED 56 0.0034
481 SEPSIS 383 0.0034
482 FEELING OF DESPAIR 16 0.0034
483 INTENTIONAL OVERDOSE 220 0.0034
484 ON AND OFF PHENOMENON 19 0.0034
485 BLOOD ALBUMIN DECREASED 27 0.0034
486 HAEMATOCHEZIA 187 0.0034
487 EMPHYSEMA 34 0.0034
488 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 26 0.0033
489 DRUG ABUSE 278 0.0033
490 SUBARACHNOID HAEMORRHAGE 34 0.0033
491 HYPERCALCAEMIA 41 0.0033
492 PSYCHOTIC DISORDER 98 0.0033
493 NERVOUS SYSTEM DISORDER 103 0.0033
494 PRODUCT AVAILABILITY ISSUE 75 0.0033
495 DEFAECATION URGENCY 23 0.0033
496 DUODENAL ULCER 23 0.0033
497 HEPATITIS 83 0.0032
498 RESPIRATORY DISORDER 97 0.0032
499 STEVENS-JOHNSON SYNDROME 72 0.0032
500 SENSORY LOSS 26 0.0032
501 UPPER GASTROINTESTINAL HAEMORRHAGE 54 0.0032
502 FOETAL EXPOSURE DURING PREGNANCY 260 0.0032
503 MATERNAL EXPOSURE DURING PREGNANCY 285 0.0032
504 BLOOD BILIRUBIN INCREASED 86 0.0032
505 BLOOD PRESSURE DECREASED 211 0.0032
506 TERMINAL STATE 21 0.0031
507 APPENDICITIS 29 0.0031
508 RALES 18 0.0031
509 SALIVARY HYPERSECRETION 31 0.0031
510 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68 0.0031
511 HEPATIC FUNCTION ABNORMAL 114 0.0031
512 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
513 INCONTINENCE 32 0.0030
514 METASTASES TO CENTRAL NERVOUS SYSTEM 39 0.0030
515 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 31 0.0030
516 ODYNOPHAGIA 18 0.0030
517 END STAGE RENAL DISEASE 55 0.0030
518 RENAL FAILURE ACUTE 127 0.0030
519 GENERALISED ERYTHEMA 17 0.0030
520 ASPARTATE AMINOTRANSFERASE INCREASED 157 0.0030
521 DECUBITUS ULCER 24 0.0029
522 MOTOR DYSFUNCTION 30 0.0029
523 METASTASES TO LUNG 34 0.0029
524 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 16 0.0029
525 FEBRILE NEUTROPENIA 194 0.0029
526 HAEMORRHOIDS 57 0.0029
527 CONCOMITANT DISEASE AGGRAVATED 18 0.0029
528 HYPONATRAEMIA 163 0.0029
529 TRANSPLANT REJECTION 23 0.0029
530 COORDINATION ABNORMAL 40 0.0029
531 POST PROCEDURAL COMPLICATION 55 0.0029
532 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
533 EXPOSURE DURING PREGNANCY 177 0.0028
534 PLEURAL EFFUSION 173 0.0028
535 ANAEMIA 542 0.0028
536 OFF LABEL USE 2487 0.0028
537 BRONCHOPULMONARY ASPERGILLOSIS 22 0.0028
538 PALLOR 77 0.0028
539 PNEUMONITIS 77 0.0028
540 HEART RATE DECREASED 99 0.0028
541 INGUINAL HERNIA 17 0.0028
542 EXTRAPYRAMIDAL DISORDER 69 0.0028
543 HEMIPARESIS 47 0.0028
544 EMBOLISM 23 0.0028
545 ACUTE MYOCARDIAL INFARCTION 81 0.0027
546 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
547 NOCTURIA 33 0.0027
548 HYPOPHOSPHATAEMIA 20 0.0027
549 HALLUCINATION, VISUAL 57 0.0027
550 SOMNOLENCE 543 0.0027
551 HYPERTENSIVE CRISIS 30 0.0027
552 MALNUTRITION 30 0.0027
553 HEPATIC ENCEPHALOPATHY 25 0.0027
554 DISORIENTATION 106 0.0027
555 ESCHERICHIA INFECTION 22 0.0027
556 HYDRONEPHROSIS 20 0.0027
557 SCREAMING 17 0.0027
558 BLOOD ALKALINE PHOSPHATASE INCREASED 66 0.0027
559 SUDDEN DEATH 28 0.0026
560 SUICIDE ATTEMPT 160 0.0026
561 EUPHORIC MOOD 27 0.0026
562 SPINAL OSTEOARTHRITIS 23 0.0026
563 LIVER INJURY 64 0.0026
564 GASTROENTERITIS 38 0.0026
565 JAUNDICE 70 0.0026
566 DEVICE RELATED INFECTION 40 0.0026
567 CARDIAC FAILURE 208 0.0026
568 BLOOD CREATININE INCREASED 169 0.0026
569 OVERDOSE 557 0.0026
570 CAESAREAN SECTION 30 0.0026
571 WITHDRAWAL SYNDROME 108 0.0026
572 MYOPATHY 22 0.0025
573 MUSCLE TWITCHING 58 0.0025
574 GENERAL PHYSICAL CONDITION ABNORMAL 17 0.0025
575 TUMOUR LYSIS SYNDROME 22 0.0025
576 DRUG WITHDRAWAL SYNDROME NEONATAL 37 0.0025
577 LOSS OF CONSCIOUSNESS 320 0.0025
578 CEREBRAL HAEMORRHAGE 89 0.0025
579 PRODUCT USE IN UNAPPROVED INDICATION 616 0.0025
580 PYREXIA 858 0.0025
581 DROOLING 17 0.0025
582 BODY TEMPERATURE INCREASED 50 0.0024
583 SUBDURAL HAEMATOMA 35 0.0024
584 ARTERIOSCLEROSIS 23 0.0024
585 DRUG INEFFECTIVE 3208 0.0024
586 POLYNEUROPATHY 29 0.0024
587 INABILITY TO AFFORD MEDICATION 24 0.0024
588 ANGIOEDEMA 106 0.0024
589 ULCER 38 0.0024
590 IRON DEFICIENCY ANAEMIA 22 0.0024
591 LIVER FUNCTION TEST INCREASED 51 0.0024
592 DYSARTHRIA 89 0.0024
593 NEPHROPATHY 22 0.0024
594 HYPOTHYROIDISM 75 0.0023
595 ABORTION INDUCED 22 0.0023
596 HICCUPS 19 0.0023
597 ASCITES 68 0.0023
598 PYELONEPHRITIS 20 0.0023
599 OSTEOPENIA 35 0.0023
600 LARGE INTESTINE PERFORATION 16 0.0023
601 GASTROINTESTINAL INFLAMMATION 18 0.0023
602 INFUSION RELATED REACTION 152 0.0023
603 AFFECTIVE DISORDER 18 0.0023
604 EOSINOPHIL COUNT INCREASED 19 0.0023
605 HYPOKINESIA 33 0.0023
606 IMMUNOSUPPRESSION 20 0.0023
607 HAEMODIALYSIS 19 0.0023
608 INJURY 156 0.0022
609 ABNORMAL FAECES 18 0.0022
610 HYPERGLYCAEMIA 80 0.0022
611 HYPOPHAGIA 56 0.0022
612 CHRONIC KIDNEY DISEASE 166 0.0022
613 ACUTE MYELOID LEUKAEMIA 34 0.0022
614 GENERALISED OEDEMA 27 0.0022
615 ATRIAL FIBRILLATION 212 0.0022
616 HALLUCINATION 164 0.0022
617 HAEMATURIA 74 0.0022
618 CONDITION AGGRAVATED 655 0.0022
619 TREATMENT FAILURE 178 0.0021
620 ERYTHEMA MULTIFORME 20 0.0021
621 DRUG ERUPTION 38 0.0021
622 WHITE BLOOD CELL COUNT INCREASED 82 0.0021
623 CONFUSIONAL STATE 345 0.0021
624 PRESCRIBED OVERDOSE 41 0.0021
625 ABNORMAL BEHAVIOUR 83 0.0021
626 MELAENA 46 0.0021
627 LIPASE INCREASED 16 0.0021
628 PULMONARY ARTERIAL HYPERTENSION 30 0.0021
629 PARKINSONISM 20 0.0020
630 PANCYTOPENIA 114 0.0020
631 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
632 C-REACTIVE PROTEIN INCREASED 74 0.0020
633 LIVE BIRTH 17 0.0020
634 DRUG SCREEN POSITIVE 16 0.0020
635 GENERAL PHYSICAL HEALTH DETERIORATION 234 0.0020
636 HEPATOTOXICITY 45 0.0020
637 WRONG DRUG ADMINISTERED 18 0.0020
638 THERAPY PARTIAL RESPONDER 31 0.0020
639 AKATHISIA 27 0.0020
640 EYELID OEDEMA 23 0.0020
641 MOVEMENT DISORDER 63 0.0020
642 PANCREATITIS ACUTE 44 0.0020
643 SMALL INTESTINAL OBSTRUCTION 24 0.0019
644 HAEMORRHAGE INTRACRANIAL 29 0.0019
645 INFLAMMATION 99 0.0019
646 ABDOMINAL PAIN 442 0.0019
647 CARDIOMYOPATHY 28 0.0019
648 NO THERAPEUTIC RESPONSE 23 0.0019
649 MANIA 31 0.0019
650 AGRANULOCYTOSIS 35 0.0019
651 NEPHROPATHY TOXIC 21 0.0019
652 DELUSION 29 0.0019
653 LUNG INFECTION 29 0.0019
654 HAEMOPTYSIS 52 0.0019
655 HYPERTENSION 394 0.0019
656 LETHARGY 107 0.0019
657 URINARY INCONTINENCE 55 0.0019
658 STAPHYLOCOCCAL INFECTION 61 0.0018
659 DYSURIA 68 0.0018
660 FACE OEDEMA 31 0.0018
661 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
662 MUCOSAL INFLAMMATION 48 0.0018
663 SPEECH DISORDER 96 0.0018
664 ACCIDENTAL OVERDOSE 67 0.0018
665 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
666 PERICARDIAL EFFUSION 42 0.0018
667 CORONARY ARTERY DISEASE 55 0.0018
668 DEEP VEIN THROMBOSIS 118 0.0018
669 COMPLETED SUICIDE 151 0.0018
670 MOOD SWINGS 57 0.0018
671 ERYTHEMA 367 0.0018
672 PNEUMONIA 575 0.0018
673 PULMONARY FIBROSIS 34 0.0018
674 AMNESIA 115 0.0018
675 RESPIRATORY TRACT INFECTION 46 0.0018
676 IRRITABILITY 106 0.0018
677 SECRETION DISCHARGE 22 0.0018
678 SKIN LACERATION 19 0.0017
679 CONSTIPATION 381 0.0017
680 BRAIN NEOPLASM 16 0.0017
681 HAEMATOMA 45 0.0017
682 MENTAL IMPAIRMENT 42 0.0017
683 HYPOAESTHESIA ORAL 26 0.0017
684 DISTURBANCE IN ATTENTION 93 0.0017
685 HYPOGLYCAEMIA 83 0.0017
686 UPPER RESPIRATORY TRACT INFECTION 79 0.0017
687 INTENTIONAL PRODUCT MISUSE 149 0.0017
688 INSURANCE ISSUE 26 0.0017
689 CYTOMEGALOVIRUS INFECTION 28 0.0017
690 PROTEINURIA 32 0.0017
691 LIP SWELLING 56 0.0017
692 CEREBRAL INFARCTION 41 0.0017
693 HEART RATE INCREASED 164 0.0017
694 SCHIZOPHRENIA 20 0.0016
695 HEPATOMEGALY 16 0.0016
696 MUSCLE SPASTICITY 20 0.0016
697 LEUKOPENIA 81 0.0016
698 GASTRITIS 42 0.0016
699 INTERSTITIAL LUNG DISEASE 77 0.0016
700 HYPERLIPIDAEMIA 19 0.0016
701 HEPATIC ENZYME INCREASED 108 0.0016
702 LYMPHOCYTE COUNT DECREASED 28 0.0016
703 ECONOMIC PROBLEM 24 0.0016
704 BREAST CANCER METASTATIC 17 0.0016
705 LIVER FUNCTION TEST ABNORMAL 46 0.0016
706 FLUID OVERLOAD 23 0.0016
707 ABDOMINAL DISTENSION 164 0.0016
708 GASTROINTESTINAL HAEMORRHAGE 131 0.0016
709 TINNITUS 72 0.0016
710 ADRENAL INSUFFICIENCY 19 0.0016
711 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
712 ANXIETY 443 0.0016
713 RASH GENERALISED 40 0.0015
714 IMPAIRED GASTRIC EMPTYING 21 0.0015
715 TENDON RUPTURE 19 0.0015
716 BASAL CELL CARCINOMA 24 0.0015
717 PLATELET COUNT INCREASED 20 0.0015
718 PRODUCT USE ISSUE 287 0.0015
719 BONE MARROW FAILURE 31 0.0015
720 METASTASES TO BONE 25 0.0015
721 NO ADVERSE EVENT 275 0.0015
722 CHOLECYSTITIS 18 0.0015
723 INTENTIONAL PRODUCT USE ISSUE 129 0.0015
724 DRUG WITHDRAWAL SYNDROME 129 0.0015
725 EATING DISORDER 31 0.0015
726 HYPERTHYROIDISM 21 0.0014
727 THINKING ABNORMAL 27 0.0014
728 SENSORY DISTURBANCE 23 0.0014
729 PRODUCT PRESCRIBING ISSUE 31 0.0014
730 DISEASE PROGRESSION 168 0.0014
731 CHROMATURIA 32 0.0014
732 DISABILITY 28 0.0014
733 PULMONARY EMBOLISM 134 0.0014
734 PULMONARY MASS 21 0.0014
735 SWOLLEN TONGUE 44 0.0014
736 NEUTROPENIA 191 0.0014
737 UNEVALUABLE EVENT 106 0.0014
738 PERITONITIS 29 0.0014
739 DYSPEPSIA 137 0.0014
740 LYMPHADENOPATHY 49 0.0014
741 CONVULSION 79 0.0014
742 HAEMORRHAGE 143 0.0014
743 EMOTIONAL DISORDER 42 0.0014
744 HAEMATOCRIT DECREASED 27 0.0014
745 DEMENTIA 38 0.0014
746 MUSCLE TIGHTNESS 22 0.0014
747 WEIGHT DECREASED 378 0.0014
748 DERMATITIS ALLERGIC 17 0.0014
749 PANIC ATTACK 49 0.0013
750 URINARY TRACT INFECTION 229 0.0013
751 HYPERHIDROSIS 172 0.0013
752 TREMOR 221 0.0013
753 HEAD INJURY 42 0.0013
754 ORTHOSTATIC HYPOTENSION 23 0.0013
755 THERAPY INTERRUPTED 94 0.0013
756 HIATUS HERNIA 17 0.0013
757 SLEEP APNOEA SYNDROME 25 0.0013
758 DYSPHAGIA 124 0.0013
759 HEPATIC STEATOSIS 24 0.0013
760 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
761 PLATELET COUNT DECREASED 136 0.0013
762 OSTEOARTHRITIS 54 0.0013
763 OEDEMA 69 0.0013
764 PANCREATITIS 67 0.0013
765 GASTRIC ULCER 24 0.0013
766 DISEASE RECURRENCE 60 0.0013
767 LOWER RESPIRATORY TRACT INFECTION 57 0.0013
768 MALIGNANT NEOPLASM PROGRESSION 128 0.0012
769 CANDIDA INFECTION 21 0.0012
770 CONJUNCTIVITIS 23 0.0012
771 RASH ERYTHEMATOUS 59 0.0012
772 DECREASED APPETITE 286 0.0012
773 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
774 NEUTROPHIL COUNT DECREASED 50 0.0012
775 EMOTIONAL DISTRESS 147 0.0012
776 BRAIN FOG 19 0.0012
777 MEMORY IMPAIRMENT 166 0.0012
778 TREATMENT NONCOMPLIANCE 66 0.0012
779 METASTASES TO LIVER 21 0.0012
780 DIVERTICULITIS 33 0.0012
781 HEPATIC CIRRHOSIS 22 0.0012
782 URTICARIA 196 0.0012
783 VOMITING 549 0.0012
784 BLOOD PRESSURE ABNORMAL 23 0.0012
785 DIPLOPIA 30 0.0012
786 INSOMNIA 304 0.0011
787 PRODUCT ADMINISTRATION ERROR 23 0.0011
788 NEUROPATHY PERIPHERAL 108 0.0011
789 DEPRESSED MOOD 60 0.0011
790 FEEDING DISORDER 23 0.0011
791 LIVER DISORDER 50 0.0011
792 RETCHING 24 0.0011
793 INCORRECT ROUTE OF DRUG ADMINISTRATION 40 0.0011
794 HYPERSOMNIA 32 0.0011
795 MEDICATION ERROR 62 0.0011
796 IMPAIRED QUALITY OF LIFE 16 0.0011
797 CELLULITIS 56 0.0011
798 FUNGAL INFECTION 37 0.0011
799 HAEMOGLOBIN DECREASED 113 0.0011
800 SUICIDAL IDEATION 100 0.0011
801 OEDEMA PERIPHERAL 132 0.0011
802 LUNG DISORDER 53 0.0011
803 MENTAL DISORDER 47 0.0011
804 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
805 BALANCE DISORDER 93 0.0011
806 DRUG EFFECT INCOMPLETE 39 0.0011
807 EPISTAXIS 80 0.0011
808 ISCHAEMIC STROKE 19 0.0011
809 THIRST 19 0.0011
810 CHILLS 124 0.0011
811 DYSPNOEA 596 0.0011
812 OSTEOMYELITIS 19 0.0010
813 NEPHROLITHIASIS 48 0.0010
814 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
815 CARDIOVASCULAR DISORDER 26 0.0010
816 PRODUCTIVE COUGH 48 0.0010
817 INFECTION 144 0.0010
818 DEPRESSION 226 0.0010
819 SCAR 17 0.0010
820 SYNCOPE 99 0.0010
821 DRUG INTOLERANCE 95 0.0010
822 STOMATITIS 58 0.0010
823 MOUTH ULCERATION 20 0.0009
824 BLOOD POTASSIUM DECREASED 28 0.0009
825 GAIT INABILITY 31 0.0009
826 EAR PAIN 18 0.0009
827 HYPERSENSITIVITY 171 0.0009
828 BLOOD GLUCOSE ABNORMAL 17 0.0009
829 GAIT DISTURBANCE 176 0.0009
830 BLOOD PRESSURE INCREASED 140 0.0009
831 WHEEZING 54 0.0009
832 CRYING 33 0.0009
833 DEHYDRATION 121 0.0009
834 MUSCULAR WEAKNESS 103 0.0009
835 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
836 PAIN 555 0.0009
837 SWELLING FACE 58 0.0009
838 RASH 387 0.0009
839 MOOD ALTERED 24 0.0009
840 MUSCULOSKELETAL STIFFNESS 77 0.0009
841 MOBILITY DECREASED 63 0.0009
842 FAECES DISCOLOURED 19 0.0009
843 CHEST PAIN 162 0.0009
844 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
845 DIABETIC KETOACIDOSIS 21 0.0009
846 ORAL HERPES 17 0.0009
847 BONE DENSITY DECREASED 27 0.0009
848 GASTROINTESTINAL DISORDER 77 0.0009
849 BACTERIAL INFECTION 16 0.0009
850 DYSPHONIA 49 0.0008
851 DISCOMFORT 51 0.0008
852 DEATH 720 0.0008
853 DRUG DEPENDENCE 134 0.0008
854 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
855 ANGER 28 0.0008
856 CHOLELITHIASIS 27 0.0008
857 CHOKING 16 0.0008
858 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
859 DIARRHOEA 517 0.0008
860 PRODUCT PRESCRIBING ERROR 19 0.0008
861 MALAISE 348 0.0008
862 ASTHENIA 295 0.0008
863 DRUG EFFECT DECREASED 42 0.0008
864 SKIN ULCER 20 0.0008
865 NAUSEA 608 0.0008
866 OSTEONECROSIS OF JAW 19 0.0008
867 COUGH 215 0.0008
868 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
869 FALL 255 0.0008
870 COVID-19 134 0.0008
871 RASH PRURITIC 41 0.0008
872 RASH MACULAR 26 0.0007
873 PRESYNCOPE 18 0.0007
874 OROPHARYNGEAL PAIN 68 0.0007
875 FLUSHING 73 0.0007
876 INTESTINAL OBSTRUCTION 27 0.0007
877 EAR INFECTION 19 0.0007
878 VISUAL IMPAIRMENT 88 0.0007
879 BLOOD PRESSURE FLUCTUATION 17 0.0007
880 PAIN IN JAW 20 0.0007
881 FLATULENCE 40 0.0007
882 RED BLOOD CELL COUNT DECREASED 20 0.0007
883 NEURALGIA 17 0.0007
884 ANGINA PECTORIS 20 0.0007
885 NECK PAIN 39 0.0007
886 SKIN DISCOLOURATION 32 0.0007
887 LACRIMATION INCREASED 21 0.0007
888 FEELING HOT 42 0.0007
889 DRUG ADMINISTRATION ERROR 21 0.0007
890 WHITE BLOOD CELL COUNT DECREASED 74 0.0007
891 OSTEOPOROSIS 28 0.0007
892 HOSPITALISATION 104 0.0007
893 BLISTER 38 0.0007
894 CATARACT 40 0.0007
895 ROAD TRAFFIC ACCIDENT 28 0.0007
896 SKIN LESION 18 0.0007
897 HEADACHE 410 0.0007
898 CARDIAC FAILURE CONGESTIVE 52 0.0006
899 WOUND 18 0.0006
900 THERAPEUTIC RESPONSE DECREASED 39 0.0006
901 HYPOAESTHESIA 96 0.0006
902 IMPAIRED HEALING 21 0.0006
903 CEREBROVASCULAR ACCIDENT 108 0.0006
904 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
905 ABDOMINAL PAIN LOWER 16 0.0006
906 PRODUCT DOSE OMISSION ISSUE 181 0.0006
907 FEMUR FRACTURE 19 0.0006
908 PRODUCT QUALITY ISSUE 83 0.0006
909 DYSPNOEA EXERTIONAL 23 0.0006
910 FEELING COLD 17 0.0006
911 LABORATORY TEST ABNORMAL 18 0.0006
912 SLEEP DISORDER 43 0.0006
913 CHEST DISCOMFORT 62 0.0006
914 TARDIVE DYSKINESIA 17 0.0006
915 MUSCLE SPASMS 107 0.0006
916 ILLNESS 60 0.0006
917 BACK PAIN 133 0.0006
918 WEIGHT INCREASED 127 0.0006
919 DRY MOUTH 46 0.0006
920 INFLUENZA 63 0.0006
921 PARAESTHESIA 88 0.0006
922 POLLAKIURIA 23 0.0006
923 DIABETES MELLITUS 42 0.0006
924 DIZZINESS 269 0.0005
925 PRODUCT SUBSTITUTION ISSUE 31 0.0005
926 RENAL DISORDER 25 0.0005
927 CONTUSION 51 0.0005
928 WRONG TECHNIQUE IN DRUG USAGE PROCESS 19 0.0005
929 FATIGUE 406 0.0005
930 DRY EYE 26 0.0005
931 ECZEMA 27 0.0005
932 SKIN DISORDER 17 0.0005
933 ARTHRALGIA 211 0.0005
934 ADVERSE DRUG REACTION 45 0.0005
935 HIP FRACTURE 16 0.0005
936 ABDOMINAL PAIN UPPER 102 0.0005
937 EXTRA DOSE ADMINISTERED 20 0.0005
938 NASAL CONGESTION 29 0.0005
939 SWELLING 46 0.0005
940 NIGHTMARE 17 0.0005
941 NEOPLASM PROGRESSION 17 0.0005
942 MYOCARDIAL INFARCTION 85 0.0005
943 EXPIRED PRODUCT ADMINISTERED 16 0.0005
944 VISION BLURRED 65 0.0005
945 MYELOSUPPRESSION 17 0.0005
946 PRURITUS 181 0.0005
947 HERPES ZOSTER 27 0.0005
948 RHINORRHOEA 30 0.0005
949 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83 0.0005
950 EYE SWELLING 17 0.0005
951 JOINT SWELLING 55 0.0005
952 PALPITATIONS 53 0.0005
953 UNDERDOSE 33 0.0005
954 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
955 MIGRAINE 42 0.0004
956 MYALGIA 74 0.0004
957 BLINDNESS 17 0.0004
958 ASTHMA 46 0.0004
959 BRONCHITIS 30 0.0004
960 DEVICE ISSUE 36 0.0004
961 INCORRECT DOSE ADMINISTERED 90 0.0004
962 BLOOD GLUCOSE INCREASED 74 0.0004
963 EYE PAIN 22 0.0004
964 PAIN IN EXTREMITY 113 0.0004
965 NERVOUSNESS 20 0.0004
966 SINUSITIS 39 0.0004
967 THROMBOSIS 30 0.0004
968 THERAPY CESSATION 19 0.0004
969 ADVERSE EVENT 34 0.0004
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 74 0.0004
971 CARDIAC DISORDER 34 0.0004
972 MUSCULOSKELETAL PAIN 19 0.0004
973 SKIN EXFOLIATION 30 0.0004
974 VERTIGO 21 0.0003
975 DYSGEUSIA 25 0.0003
976 NASOPHARYNGITIS 61 0.0003
977 PERIPHERAL SWELLING 50 0.0003
978 SURGERY 19 0.0003
979 FEELING ABNORMAL 77 0.0003
980 ARTHRITIS 25 0.0003
981 NEOPLASM MALIGNANT 21 0.0003
982 BURNING SENSATION 22 0.0003
983 ILL-DEFINED DISORDER 19 0.0003
984 BONE PAIN 18 0.0003
985 ABDOMINAL DISCOMFORT 48 0.0003
986 DEVICE MALFUNCTION 19 0.0003
987 DRY SKIN 35 0.0003
988 ALOPECIA 50 0.0003
989 INFLUENZA LIKE ILLNESS 20 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
991 INJECTION SITE PAIN 47 0.0002
992 INJECTION SITE ERYTHEMA 19 0.0002